Archive
All News
Every briefing, headline, and filing we've published, newest first.
MoneyBioPharma Dive ↗
Research Alliance III follows a few months after Cormorant Asset Management priced a $150 million IPO for its …
PolicyKFF Health News ↗
This analysis explores recent actions the Trump administration has taken to limit youth access to gender-affir…
PolicyKFF Health News ↗
This brief explains current Medicaid cost sharing rules and changes made to cost sharing rules by the 2025 rec…
PolicyPharmaVoice ↗
The nonprofit is aiming to inspire a new moonshot effort that helps the U.S. maintain its position as a drug i…
DealsFierceBiotech ↗
London-based Global Healthcare Opportunities and Singapore-based CBC Group announced plans to merge, creating …
PolicyFiercePharma ↗
Takeda plans to appeal after a federal jury found it liable in a landmark pay-for-delay antitrust case and ord…
PipelineBriefing
The global phase 3 win gives Merck’s sacituzumab tirumotecan fresh momentum across 17 ongoing ADC trials, offe…
PipelinePharmaceutical Technology ↗
48 weeks of Trikafta treatment improved lung capacity and inflammation biomarkers among CF patients.…
PolicyKFF Health News ↗
This tracker examines Executive Actions taken by the Trump administration that have the potential to impact LG…
PipelineSTAT News ↗
A UCSF team has submitted an application to the FDA seeking approval for a small trial of in utero gene therap…
PolicyEndpoints News ↗
Last week at our biopharma and healthcare summit with the Financial Times, I was asked during one of our break…
DealsFierceBiotech ↗
With the ink barely dry on an antibody-drug conjugate-style deal with Regeneron, Parabilis Medicines has now t…
PipelineFiercePharma ↗
After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor Pharma and its aldosterone syntha…
DealsBriefing
After a failed A-T trial and cash crunch, Quince merges with Orphai Therapeutics, keeping its Nasdaq listing a…
NegotiationsDrug Channels ↗
Here at Drug Channels, we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) indu…
PolicySTAT News ↗
It's part of Democrats' strategy to focus on health care affordability and access in drawing contrasts with Re…
PipelineFiercePharma ↗
Already tracking $5 billion in annual sales, Enhertu has secured two new FDA approvals for treating early brea…
DealsFierceBiotech ↗
Regeneron has ponied up $125 million in cash and an equity investment in Parabilis Medicines to join forces on…
PolicyBriefing
The Justices declined to review challenges from AstraZeneca, Novo Nordisk, and others, leaving CMS authority o…
DataKFF Health News ↗
The average Affordable Care Act (ACA) Marketplace deductible experienced the steepest increase in history—grow…
PolicySTAT News ↗
With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknow…
PipelinePharmaVoice ↗
As next-generation GLP-1 contenders rise, key readouts are on the way from Pfizer, Viking Therapeutics and Eli…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.